Literature DB >> 18201560

Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery.

Bing Liang1, Ming-Liang He, Zhong-Peng Xiao, Yi Li, Chu-Yan Chan, Hsiang-Fu Kung, Xin-Tao Shuai, Ying Peng.   

Abstract

A great challenge for gene therapy is to develop a high efficient gene delivery system with low toxicity. Nonviral vectors are still attractive although the current agents displayed some disadvantages (i.e., low transfection efficiency, high toxicity). To overcome the high toxicity of poly(ethylene imine) (PEI) and low transfection efficiency of PEGylated PEI (PEG-PEI), we linked a cell specific target molecule folate (FA) on poly(ethylene glycol) (PEG) and then grafted the FA-PEG onto hyperbranched PEI 25kDa. The FA-PEG- grafted-hyperbranched-PEI (FA-PEG-PEI) effectively condensed plasmid DNA (pDNA) into nanoparticles with positive surface charge under a suitable N/P ratio. Tested in deferent cell lines (i.e., HEK 293T, glioma C6 and hepatoma HepG2 cells), no significant cytotoxicity of FA-PEG-PEI was added to PEG-PEI. More importantly, significant transfection efficiency was exhibited in FA-targeted cells. Reporter assay showed that FA-PEG-PEI/pDNA complexes had significantly higher transgene activity than that of PEI/pDNA in folate-receptor (FR) positive (HEK 293T and C6) cells but not FR-negative (HepG2) cells. These results indicated that FA-PEG-PEI might be a promising candidate for gene delivery with the characteristics of good biocompatibility, potential biodegradability, and relatively high gene transfection efficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18201560     DOI: 10.1016/j.bbrc.2008.01.024

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  A novel polymer-lipid hybrid nanoparticle for efficient nonviral gene delivery.

Authors:  Jian Li; Ying-zi He; Wen Li; Yun-zhen Shen; Yu-ru Li; Yun-feng Wang
Journal:  Acta Pharmacol Sin       Date:  2010-03-29       Impact factor: 6.150

Review 2.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

3.  Folic Acid/Peptides Modified PLGA-PEI-PEG Polymeric Vectors as Efficient Gene Delivery Vehicles: Synthesis, Characterization and Their Biological Performance.

Authors:  Chaoyu Liu; Yuancai Xie; Xiaohua Li; Xumei Yao; Xuanbin Wang; Min Wang; Zongxian Li; Fengjun Cao
Journal:  Mol Biotechnol       Date:  2020-11-03       Impact factor: 2.695

Review 4.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

Review 5.  Insights into atherosclerosis using nanotechnology.

Authors:  Ashwath Jayagopal; Macrae F Linton; Sergio Fazio; Frederick R Haselton
Journal:  Curr Atheroscler Rep       Date:  2010-05       Impact factor: 5.113

6.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

7.  Novel pentablock copolymers for selective gene delivery to cancer cells.

Authors:  Bingqi Zhang; Mathumai Kanapathipillai; Paul Bisso; Surya Mallapragada
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

8.  The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.

Authors:  Ying Wu; Weiwei Wang; Yinting Chen; Kaihong Huang; Xintao Shuai; Qikui Chen; Xuexian Li; Guoda Lian
Journal:  Int J Nanomedicine       Date:  2010-03-09

9.  A potential targeting gene vector based on biotinylated polyethyleneimine/avidin bioconjugates.

Authors:  Xuan Zeng; Yun-Xia Sun; Xian-Zheng Zhang; Si-Xue Cheng; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

10.  Delivery of therapeutic AGT shRNA by PEG-Bu for hypertension therapy.

Authors:  Yu-Qiang Wang; Fei Wang; Xiao-Qin Deng; Jing Sheng; Shu-Yan Chen; Jing Su
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.